Treatment-naïve, Sputum Smear-positive Patients With Drug-sensitive Pulmonary TB
1 clinical trials · Condition
◉ Watch Treatment-naïve, Sputum Smear-positive Patients With Drug-sensitive Pulmonary TB
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Study to Evaluate Early Bactericidal Activity, Safety, Tolerability, and Pharmacokinetics of Multiple Oral Doses of Telacebec (Q203) (NCT03563599) | Qurient Co., Ltd. | 2018-07-23 |
Track Treatment-naïve, Sputum Smear-positive Patients With Drug-sensitive Pulmonary TB automatically
Every clearance here is in the API, with alerts when new ones post.